CNSP (STOCKS)
CNS Pharmaceuticals, Inc. Common Stock
$2.520000
+0.340000 (+15.60%)
Prev close: $2.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Rami Levin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1.98M
- Employees
- 4
- P/E (TTM)
- -0.06
- P/B (TTM)
- 0.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-10.15 | $-5.19 | -4.9582 | -95.50% |
|
Sep 2025 (Q3)
|
$-5.76 | $-7.24 | +1.4769 | +20.41% |
|
Jun 2025 (Q2)
|
$-6.42 | $-9.79 | +3.3720 | +34.44% |
|
Dec 2024 (Q4)
|
$-111.00 | $-118.24 | +7.2384 | +6.12% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $136.00K |
| Operating Expenses | $15.99M |
| Research and Development | $9.77M |
| Other Operating Expenses | $6.21M |
| Operating Income/Loss | -$15.99M |
| Income/Loss From Continuing Operations After Tax | -$15.85M |
| Income/Loss From Continuing Operations Before Tax | -$15.85M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$15.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$35.75 |
| Diluted Earnings Per Share | -$35.75 |
| Basic Average Shares | 443,369 |
| Diluted Average Shares | 443,369 |
| Assets | $8.62M |
| Current Assets | $8.10M |
| Noncurrent Assets | $520.67K |
| Fixed Assets | $17.70K |
| Non-current Prepaid Expenses | $502.96K |
| Liabilities | $4.10M |
| Current Liabilities | $4.10M |
| Noncurrent Liabilities | $0.00 |
| Equity | $4.52M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.52M |
| Liabilities And Equity | $8.62M |
| Net Cash Flow From Operating Activities | -$13.81M |
| Net Cash Flow From Operating Activities, Continuing | -$13.81M |
| Net Cash Flow From Investing Activities | -$18.18K |
| Net Cash Flow From Investing Activities, Continuing | -$18.18K |
| Net Cash Flow From Financing Activities | $14.57M |
| Net Cash Flow From Financing Activities, Continuing | $14.57M |
| Net Cash Flow | $739.64K |
| Net Cash Flow, Continuing | $739.64K |
| Comprehensive Income/Loss | -$15.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.85M |
| Other Comprehensive Income/Loss | $0.00 |